Synephrine

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: weight energy focus

Research Overview

Human research on synephrine has most commonly examined (1) acute thermogenic/metabolic effects relevant to weight management and (2) short-term cardiovascular and hemodynamic safety (blood pressure, heart rate, ECG/QTc), typically in healthy, normotensive adults. Several studies use bitter orange extract standardized to synephrine, while fewer isolate p-synephrine alone; some also evaluate combinations (e.g., with citrus flavonoids such as naringin/hesperidin or with caffeine). A related line of work has quantified synephrine exposure from Seville orange juice and assessed its short-term cardiovascular effects, reflecting interest in real-world dietary intake and potential drug/condition interactions.

The strongest evidence from these studies supports that, in healthy adults, typical single doses or short courses of p-synephrine/bitter orange extract often do not produce clinically meaningful changes in heart rate, blood pressure, or ECG parameters, including QTc, under the tested conditions (including repeated daily dosing for 15 days in one crossover study). Evidence for metabolic effects is more limited but suggests p-synephrine can acutely increase resting metabolic rate, and that co-administration with certain flavonoids may amplify this thermogenic response without concomitant increases in heart rate or blood pressure in the short term. However, findings are not fully consistent across products and protocols: at least one controlled crossover study reported modest but statistically significant acute increases in systolic/diastolic blood pressure and heart rate after a single bitter orange supplement dose, whereas other single-dose studies reported no significant hemodynamic changes.

Key gaps include longer-term, adequately powered trials that evaluate sustained weight-loss efficacy (not just acute RMR changes), dose–response relationships, and safety in higher-risk populations (e.g., hypertension, arrhythmias, glaucoma, MAOI use) and in common real-world combinations (notably with caffeine and multi-ingredient “ephedra-free” products). Additional research is needed to reconcile heterogeneity across studies (p-synephrine vs mixed isomers; extract standardization; co-ingredients; baseline caffeine intake), to better characterize pharmacokinetics and interaction potential (including with CYP3A4-related contexts), and to improve adverse-event surveillance beyond short observation windows in healthy volunteers.

1. What conditions has Synephrine been studied for?

  • Weight loss / obesity and weight management: Bitter orange (Citrus aurantium) extract and p-synephrine are widely used and studied in the context of “ephedra-free” weight-loss supplements, including pilot obesity trials and multiple placebo-controlled human studies.

  • Thermogenesis / resting metabolic rate (RMR) enhancement: Acute studies measured changes in RMR after p-synephrine alone and in combination with flavonoids (naringin, hesperidin).

  • Cardiovascular safety (blood pressure, heart rate, ECG/QTc): Multiple acute and short-term studies evaluated hemodynamics and ECG parameters after bitter orange extract or p-synephrine, including single-dose crossover trials and repeated dosing (e.g., 15 days; 60 days).

  • Drug-metabolism interaction context (CYP3A4 “knockout”): Seville orange juice is used in research to reduce intestinal CYP3A4 activity; one abstract focused on synephrine/octopamine content and cardiovascular effects of Seville orange juice in humans.

  • Mood/subjective stimulation and basic lab markers: Acute studies assessed mood perception and hematology/chemistry panels with p-synephrine alone and with caffeine.

2. Does it work in treating those conditions? Summarize the evidence.

  • Weight loss/obesity: The included meta-analysis (18 placebo-controlled human trials) reported that weight loss with synephrine was non-significant after prolonged treatment and it did not meaningfully influence body composition parameters. This suggests no reliable evidence of clinically meaningful weight loss from synephrine based on the analyzed trials.

  • Thermogenesis/RMR (acute): In a randomized, double-blind, placebo-controlled study (10 subjects/group), p-synephrine 50 mg increased RMR versus placebo (placebo decreased ~30 kcal from baseline; p-synephrine showed a relative increase). Adding naringin 600 mg and hesperidin 100 mg produced a larger RMR increase (reported as statistically significant vs placebo, p<0.02 for the 100 mg hesperidin combination). However, a higher hesperidin dose (1000 mg) did not produce a larger effect, suggesting an inconsistent dose-response.

  • Cardiovascular safety endpoints: Evidence is mixed. Several controlled studies found no significant changes in heart rate, blood pressure, ECG, or QTc after single doses (e.g., 27 mg synephrine in one crossover trial) and after repeated dosing (e.g., ~49 mg p-synephrine daily for 15 days; ~98 mg/day for 60 days). In contrast, one crossover study using a commercial bitter orange product (900 mg extract standardized to 6% synephrine) found significant increases in systolic BP, diastolic BP, and HR for up to 5 hours after a single dose (peak SBP difference ~7.3 mmHg; HR difference ~4.2 bpm).

  • Stimulant-like effects/mood: In acute quiet-sitting studies, p-synephrine (about 103–104 mg) did not increase HR and did not produce stimulant-like mood effects; caffeine-containing arms increased feelings such as attention/energy, indicating those effects were attributable to caffeine rather than synephrine in that study.

3. What health benefits does it have?

  • Acute increase in resting metabolic rate (thermogenic effect): p-synephrine (50 mg) increased RMR versus placebo in one controlled study, and combinations with naringin and hesperidin increased RMR further (with one combination reaching statistical significance vs placebo). This is a potential mechanistic benefit relevant to weight management, but it is not the same as proven long-term weight loss.

  • Possible neutral (or minimal) acute subjective stimulation: In studies measuring mood and symptom ratings, p-synephrine alone did not produce stimulant-like perceptual effects and did not worsen self-reported symptom ratings versus placebo in the acute thermogenesis study.

  • Possible favorable acute lipid-related changes (limited evidence): In one acute study, p-synephrine was associated with decreases in triglycerides and VLDL versus placebo over a short period; this finding is preliminary and not clearly linked to clinical outcomes.

Overall, the studies support short-term thermogenic effects in some settings, but the meta-analysis summarized here found no convincing evidence of meaningful weight loss with prolonged use.

4. Does it have any downsides or side effects?

  • Blood pressure and heart rate increases (in some studies): One randomized crossover trial in healthy young adults found bitter orange increased SBP (peak difference ~7.3 mmHg), DBP (peak difference ~2.6 mmHg), and HR (peak difference ~4.2 bpm) for several hours post-dose versus placebo.

  • Meta-analysis signal for increased BP with prolonged use: The meta-analysis reported statistically significant increases after prolonged use: SBP +6.37 mmHg (95% CI 1.02–11.72) and DBP +4.33 mmHg (95% CI 0.48–8.18). It also concluded synephrine tends to raise BP and HR, while not supporting weight-loss efficacy.

  • Conflicting safety findings across trials: Multiple placebo-controlled studies reported no significant changes in HR, BP, ECG/QTc, blood chemistries, or adverse event reporting with bitter orange extract providing ~49 mg p-synephrine (15 days) or ~98 mg/day (60 days), and a single-dose trial with 27 mg synephrine found no BP/QTc effect. Differences in products (standardization, isomer content, co-ingredients), dosing, and study size likely contribute to inconsistent results.

  • Populations advised to avoid Seville orange juice (cautionary guidance): Although Seville orange juice did not significantly change hemodynamics in normotensive subjects, the study advises avoidance in people with severe hypertension, tachyarrhythmias, narrow-angle glaucoma, those taking monoamine oxidase inhibitors, and those using decongestant-containing cold preparations. This reflects theoretical/known sympathomimetic risk and interaction concerns.

  • Combination with caffeine: In quiet-sitting studies, adding p-synephrine to caffeine did not clearly augment SBP or HR beyond caffeine alone at the tested doses, but caffeine itself increased subjective stimulation. Real-world supplements often combine multiple stimulants, which may change risk.

Key limitation across the studies: many studies are small, short-term, and use different bitter orange preparations (and sometimes combinations), making it hard to generalize safety to all products and long-term use.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not report pharmacogenomic analyses (e.g., outcomes stratified by genetic variants in adrenergic receptors, MAO enzymes, or CYP enzymes), so no direct evidence can be drawn about specific genetic variations altering benefit or harm.

  • CYP3A4 context is not pharmacogenomics here: One abstract notes Seville orange juice is used to reduce intestinal CYP3A4 activity in bioavailability studies, but it did not evaluate genetic variants (e.g., CYP3A4/3A5 genotypes) or genotype-dependent effects.

  • Mechanistic plausibility but unproven: Because synephrine has sympathomimetic properties, it is plausible that variants affecting catecholamine signaling/metabolism could influence responses, but this is not tested in the cited studies.

References

  1. Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes
    Sidney J Stohs, Harry G Preuss, Samuel C Keith, Patti L Keith, Howard Miller (2011)
  2. Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults
    S R Penzak, M W Jann, J A Cold, Y Y Hon, H D Desai (2001)
  3. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study
    Mohd Shara, Sidney J Stohs, Mahmoud M Smadi (2018)
  4. Blood pressure and heart rate effects following a single dose of bitter orange
    Linda T Bui, DiemThuy T Nguyen, Peter J Ambrose (2006)
  5. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects
    Bokyung Min, Deborah Cios, Jeffrey Kluger, C Michael White (2005)
  6. Acute cardiovascular effects of bitter orange extract (p-synephrine) consumed alone and in combination with caffeine in human subjects: A placebo-controlled, double-blind study
    Nicholas A Ratamess, Jill A Bush, Sidney J Stohs, Nicole L Ellis, Ira T Vought (2018)
  7. Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial
    Mohd Shara, Sidney J Stohs, Tareq L Mukattash (2016)
  8. The Safety and Efficacy ofCitrus aurantium(Bitter Orange) Extracts andp-Synephrine: A Systematic Review and Meta-Analysis
    Dorottya Koncz, Barbara Tóth, Muh Akbar Bahar, Orsolya Roza, Dezső Csupor (2022)
  9. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract
    Gilbert R Kaats, Howard Miller, Harry G Preuss, Sidney J Stohs (2013)
  10. Acute hematological and mood perception effects of bitter orange extract (p-synephrine) consumed alone and in combination with caffeine: A placebo-controlled, double-blind study
    Jill A Bush, Nicholas A Ratamess, Sidney J Stohs, Nicole L Ellis, Ira T Vought (2018)
  11. Dietary herbal supplements with phenylephrine for weight loss
    Frank Greenway, Lilian de Jonge-Levitan, Corby Martin, Andrew Roberts, Irene Grundy (2006)
  12. Effects of p-Synephrine and Caffeine Ingestion on Substrate Oxidation during Exercise
    Jorge Gutiérrez-Hellín, Juan Del Coso (2018)
  13. Acute p-synephrine ingestion increases whole-body fat oxidation during 1-h of cycling at Fatmax
    Jorge Gutiérrez-Hellín, Carlos Ruiz-Moreno, Juan Del Coso (2020)
  14. Acute p-synephrine ingestion increases fat oxidation rate during exercise
    Jorge Gutiérrez-Hellín, Juan Del Coso (2016)
  15. Effect ofp-Synephrine on Fat Oxidation Rate during Exercise of Increasing Intensity in Healthy Active Women
    Jorge Gutiérrez-Hellín, Millán Aguilar-Navarro, Carlos Ruiz-Moreno, Alejandro Muñoz, Francisco J Amaro-Gahete (2022)
  16. Does the Time of Day Play a Role in the Acute Effect ofp-Synephrine on Fat Oxidation Rate during Exercise in Women? A Randomized, Crossover and Double-Blind Study
    Jorge Gutiérrez-Hellín, Juan Del Coso, Millán Aguilar-Navarro, David Varillas-Delgado, Carlos Ruiz-Moreno (2022)
  17. Acute consumption of p-synephrine does not enhance performance in sprint athletes
    Jorge Gutiérrez-Hellín, Juan José Salinero, Javier Abían-Vicen, Francisco Areces, Beatriz Lara (2016)
  18. Bitter Orange(Citrus aurantium L.)Intake Before Submaximal Aerobic Exercise Is Safe for Cardiovascular and Autonomic Systems in Healthy Males: A Randomized Trial
    Cicero Jonas R Benjamim, Francisco Welington de Sousa Júnior, Andrey Alves Porto, Élida Mara B Rocha, Milana D Santana (2022)
  19. The Effects of Supplementation with p-Synephrine Alone and in Combination with Caffeine on Metabolic, Lipolytic, and Cardiovascular Responses during Resistance Exercise
    Nicholas A Ratamess, Jill A Bush, Jie Kang, William J Kraemer, Sidney J Stohs (2016)


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!